TD Waterhouse Canada’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
TD Waterhouse Canada's ABCL Position: Q3 2026 in Review
TD Waterhouse Canada reduced its AbCellera Biologics (ABCL) stake by 3.6% in Q3 2026, selling an estimated $3.28M and leaving 9,222,005 shares worth $128M. The position accounts for 0.33% of the portfolio, ranked #57.
TD Waterhouse Canada first reported a position in ABCL in Q4 2021 and has held it in 20 quarters since. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- TD Waterhouse Canada held 9,222,005 shares of AbCellera Biologics worth $128M as of Q3 2026.
- TD Waterhouse Canada sold 346,144 AbCellera Biologics shares in Q3 2026, an estimated $3.28M.
- AbCellera Biologics made up 0.33% of TD Waterhouse Canada's portfolio in Q3 2026, its #57 holding.
- TD Waterhouse Canada first reported a position in AbCellera Biologics in Q4 2021 and has held it in 20 quarters since.
- 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on TD Waterhouse Canada's 13F filing for Q3 2026, filed 16 Oct 2026.